IL4I1 and central nervous system cancer: In addition, studies have shown that Interleukin 4-inducible-1 (IL4I1), another enzyme in the tryptophan metabolism, is negatively correlated with the overall survival (OS) of glioma patients (Sadik et al., 2020).